

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.33905903 |
| 2 | proteasome assembly (GO:0043248) | 5.35051152 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 4.49097712 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.40826404 |
| 5 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.40271031 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.39911675 |
| 7 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.33898511 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 4.21263188 |
| 9 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.16187041 |
| 10 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.11736643 |
| 11 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.08297424 |
| 12 | viral transcription (GO:0019083) | 4.05272745 |
| 13 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.04228550 |
| 14 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.01406024 |
| 15 | negative regulation of ligase activity (GO:0051352) | 4.01406024 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 3.99357093 |
| 17 | translational termination (GO:0006415) | 3.99183649 |
| 18 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.96920488 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.95113462 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.92531166 |
| 21 | nucleobase biosynthetic process (GO:0046112) | 3.84968602 |
| 22 | DNA strand elongation (GO:0022616) | 3.80106797 |
| 23 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.77788035 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.77552752 |
| 25 | translational elongation (GO:0006414) | 3.77439450 |
| 26 | extracellular fibril organization (GO:0043206) | 3.75819991 |
| 27 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.71937827 |
| 28 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.71802387 |
| 29 | translational initiation (GO:0006413) | 3.71511114 |
| 30 | ribosomal small subunit biogenesis (GO:0042274) | 3.69227094 |
| 31 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.68849866 |
| 32 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.68786704 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 3.61172045 |
| 34 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.60666272 |
| 35 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.60666272 |
| 36 | protein targeting to ER (GO:0045047) | 3.60572879 |
| 37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.59477934 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.59477934 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.59477934 |
| 40 | positive regulation of ligase activity (GO:0051351) | 3.58970287 |
| 41 | folic acid metabolic process (GO:0046655) | 3.58941450 |
| 42 | DNA replication checkpoint (GO:0000076) | 3.58233325 |
| 43 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.50588474 |
| 44 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.50588474 |
| 45 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49480554 |
| 46 | protein deneddylation (GO:0000338) | 3.47860236 |
| 47 | folic acid transport (GO:0015884) | 3.45859316 |
| 48 | ribosomal large subunit biogenesis (GO:0042273) | 3.45333777 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.44725845 |
| 50 | fibril organization (GO:0097435) | 3.43974129 |
| 51 | translation (GO:0006412) | 3.43275178 |
| 52 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.43068631 |
| 53 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.42078857 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.41589929 |
| 55 | ribosome biogenesis (GO:0042254) | 3.41427685 |
| 56 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.41223470 |
| 57 | DNA replication initiation (GO:0006270) | 3.40437441 |
| 58 | regulation of mitochondrial translation (GO:0070129) | 3.39457465 |
| 59 | ribosome assembly (GO:0042255) | 3.36714744 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.36484559 |
| 61 | telomere maintenance via recombination (GO:0000722) | 3.32069108 |
| 62 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.30721300 |
| 63 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.29181323 |
| 64 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.25679362 |
| 65 | cullin deneddylation (GO:0010388) | 3.25184066 |
| 66 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.24776563 |
| 67 | termination of RNA polymerase III transcription (GO:0006386) | 3.24776563 |
| 68 | pseudouridine synthesis (GO:0001522) | 3.24368215 |
| 69 | cell cycle G1/S phase transition (GO:0044843) | 3.22948739 |
| 70 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.22948739 |
| 71 | viral life cycle (GO:0019058) | 3.22431685 |
| 72 | GDP-mannose metabolic process (GO:0019673) | 3.21786735 |
| 73 | regulation of ligase activity (GO:0051340) | 3.19327385 |
| 74 | oxidative phosphorylation (GO:0006119) | 3.16893591 |
| 75 | rRNA modification (GO:0000154) | 3.15814037 |
| 76 | regulation of platelet aggregation (GO:0090330) | 3.15678645 |
| 77 | cellular protein complex disassembly (GO:0043624) | 3.14709865 |
| 78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13474343 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.11534817 |
| 80 | iron-sulfur cluster assembly (GO:0016226) | 3.10900722 |
| 81 | metallo-sulfur cluster assembly (GO:0031163) | 3.10900722 |
| 82 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.09158434 |
| 83 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.08026131 |
| 84 | positive regulation of cell cycle arrest (GO:0071158) | 3.04152031 |
| 85 | thrombin receptor signaling pathway (GO:0070493) | 3.03928677 |
| 86 | adenosine receptor signaling pathway (GO:0001973) | 3.03904403 |
| 87 | rRNA processing (GO:0006364) | 3.03838241 |
| 88 | actin nucleation (GO:0045010) | 2.99173024 |
| 89 | positive regulation of receptor recycling (GO:0001921) | 2.98417616 |
| 90 | cyclooxygenase pathway (GO:0019371) | 2.96770137 |
| 91 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.96682744 |
| 92 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.96429503 |
| 93 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.96097382 |
| 94 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.96097382 |
| 95 | pinocytosis (GO:0006907) | 2.95375890 |
| 96 | protein targeting to mitochondrion (GO:0006626) | 2.95370881 |
| 97 | establishment of protein localization to mitochondrion (GO:0072655) | 2.95346258 |
| 98 | spliceosomal snRNP assembly (GO:0000387) | 2.95254184 |
| 99 | endothelium development (GO:0003158) | 2.94822265 |
| 100 | heart process (GO:0003015) | 2.94664285 |
| 101 | heart contraction (GO:0060047) | 2.94664285 |
| 102 | platelet aggregation (GO:0070527) | 2.94579869 |
| 103 | response to thyroid hormone (GO:0097066) | 2.93325687 |
| 104 | L-methionine biosynthetic process (GO:0071265) | 2.92904476 |
| 105 | amino acid salvage (GO:0043102) | 2.92904476 |
| 106 | L-methionine salvage (GO:0071267) | 2.92904476 |
| 107 | regulation of platelet activation (GO:0010543) | 2.92477948 |
| 108 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.91282579 |
| 109 | rRNA metabolic process (GO:0016072) | 2.89228848 |
| 110 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.88980943 |
| 111 | mitotic recombination (GO:0006312) | 2.86821783 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.86201314 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.85967867 |
| 114 | response to peptidoglycan (GO:0032494) | 2.85486587 |
| 115 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.83937568 |
| 116 | cellular component biogenesis (GO:0044085) | 2.83467930 |
| 117 | phagocytosis, engulfment (GO:0006911) | 2.82283341 |
| 118 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.81255428 |
| 119 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.80981106 |
| 120 | telomere maintenance via telomere lengthening (GO:0010833) | 2.80827239 |
| 121 | negative regulation of interleukin-17 production (GO:0032700) | 2.80069379 |
| 122 | 7-methylguanosine mRNA capping (GO:0006370) | 2.78421839 |
| 123 | ATP synthesis coupled proton transport (GO:0015986) | 2.78181381 |
| 124 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.78181381 |
| 125 | positive regulation of lamellipodium assembly (GO:0010592) | 2.77279444 |
| 126 | regulation of cellular amine metabolic process (GO:0033238) | 2.76945517 |
| 127 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.76928998 |
| 128 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.76928998 |
| 129 | galactose catabolic process (GO:0019388) | 2.76092325 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75751831 |
| 131 | positive regulation of mast cell degranulation (GO:0043306) | 2.75751831 |
| 132 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.74629638 |
| 133 | regulation of protein heterodimerization activity (GO:0043497) | 2.72977502 |
| 134 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.72658073 |
| 135 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.72074192 |
| 136 | protein localization to mitochondrion (GO:0070585) | 2.71988476 |
| 137 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.71589284 |
| 138 | cellular response to arsenic-containing substance (GO:0071243) | 2.70560896 |
| 139 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.70514692 |
| 140 | platelet degranulation (GO:0002576) | 2.69987790 |
| 141 | oxygen transport (GO:0015671) | 2.69153838 |
| 142 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.68898598 |
| 143 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.65821519 |
| 144 | glycosphingolipid catabolic process (GO:0046479) | 2.64607002 |
| 145 | regulation of receptor recycling (GO:0001919) | 2.64528734 |
| 146 | lipoxygenase pathway (GO:0019372) | 2.64523266 |
| 147 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61838814 |
| 148 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.60554890 |
| 149 | gas transport (GO:0015669) | 2.57930101 |
| 150 | positive regulation of mast cell activation (GO:0033005) | 2.55904054 |
| 151 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.53559106 |
| 152 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.49976766 |
| 153 | peptide catabolic process (GO:0043171) | 2.49471394 |
| 154 | relaxation of smooth muscle (GO:0044557) | 2.47962353 |
| 155 | NADH metabolic process (GO:0006734) | 2.44180339 |
| 156 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.42027465 |
| 157 | regulation of leukocyte degranulation (GO:0043300) | 2.41423524 |
| 158 | glycolipid catabolic process (GO:0019377) | 2.40942264 |
| 159 | regulation of macrophage cytokine production (GO:0010935) | 2.40044421 |
| 160 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.38830866 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.38103385 |
| 162 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.37621116 |
| 163 | detection of molecule of bacterial origin (GO:0032490) | 2.37495673 |
| 164 | negative regulation of cation channel activity (GO:2001258) | 2.36822046 |
| 165 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36364580 |
| 166 | angiogenesis involved in wound healing (GO:0060055) | 2.36212233 |
| 167 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.35535052 |
| 168 | blood coagulation, intrinsic pathway (GO:0007597) | 2.35325298 |
| 169 | protein localization to endosome (GO:0036010) | 2.33981909 |
| 170 | immunoglobulin mediated immune response (GO:0016064) | 2.31857236 |
| 171 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.29447624 |
| 172 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.28273973 |
| 173 | phagosome maturation (GO:0090382) | 2.26722799 |
| 174 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.26499606 |
| 175 | positive regulation of macrophage cytokine production (GO:0060907) | 2.26112810 |
| 176 | mitochondrial calcium ion transport (GO:0006851) | 2.25969173 |
| 177 | negative regulation of heart rate (GO:0010459) | 2.24996417 |
| 178 | regulation of superoxide anion generation (GO:0032928) | 2.24422794 |
| 179 | detection of other organism (GO:0098543) | 2.24138789 |
| 180 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.24133375 |
| 181 | detection of external biotic stimulus (GO:0098581) | 2.24104968 |
| 182 | microglial cell activation (GO:0001774) | 2.23970781 |
| 183 | prostanoid biosynthetic process (GO:0046457) | 2.23404207 |
| 184 | prostaglandin biosynthetic process (GO:0001516) | 2.23404207 |
| 185 | positive regulation of B cell differentiation (GO:0045579) | 2.23314366 |
| 186 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.22889392 |
| 187 | actin filament polymerization (GO:0030041) | 2.22279056 |
| 188 | purine nucleotide salvage (GO:0032261) | 2.21065014 |
| 189 | triglyceride catabolic process (GO:0019433) | 2.21002751 |
| 190 | negative regulation of heart contraction (GO:0045822) | 2.18617312 |
| 191 | regulation of metalloenzyme activity (GO:0048552) | 2.18395997 |
| 192 | neutrophil activation (GO:0042119) | 2.17669660 |
| 193 | positive regulation of hemostasis (GO:1900048) | 2.17303462 |
| 194 | positive regulation of blood coagulation (GO:0030194) | 2.17303462 |
| 195 | cellular response to epinephrine stimulus (GO:0071872) | 2.16274326 |
| 196 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.15415021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.44130520 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11000896 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.03452595 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.78143738 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.20458630 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.13944380 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.10635324 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.00460608 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.94315032 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.89234265 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.86358722 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.86193217 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.84103500 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72021446 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55368532 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.54437093 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.44485478 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.43982058 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43714348 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42591213 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24089227 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20906059 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17960136 |
| 24 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.16437012 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.16333024 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14521604 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14204213 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.12200116 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08346772 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.07535726 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.07488052 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06843517 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.05690986 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04289450 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03114232 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.02804188 |
| 37 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.00116783 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.99629301 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88609576 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.86975918 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85981425 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85849007 |
| 43 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.85227861 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.85100619 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84164249 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83185504 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.83088949 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80375542 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74913975 |
| 50 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72876426 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.71759410 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.71756421 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.69961657 |
| 54 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69210010 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68083930 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66901074 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66301389 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66081190 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64926132 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.63732176 |
| 61 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.63442156 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.63036930 |
| 63 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62699571 |
| 64 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61395545 |
| 65 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.60679092 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60506087 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58370169 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.55980299 |
| 69 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.55880103 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53410520 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50126915 |
| 72 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48769298 |
| 73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48544919 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48314021 |
| 75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48296943 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47839897 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47838624 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45605422 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44142253 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.42457726 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38875476 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38052845 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37353787 |
| 84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36802244 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33547472 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33373467 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33081943 |
| 88 | MYC_22102868_ChIP-Seq_BL_Human | 1.32851767 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32632698 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32608070 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32383002 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32360182 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31970008 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30392420 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30353963 |
| 96 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30150659 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29073088 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28584507 |
| 99 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27881739 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27265404 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26690645 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26290903 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25880944 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23698287 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22923480 |
| 106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22387486 |
| 107 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22342325 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22313901 |
| 109 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21758655 |
| 110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21122619 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20801958 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20629543 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19920384 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19098762 |
| 115 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17649780 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16945331 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16770242 |
| 118 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15388138 |
| 119 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14139188 |
| 120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14130224 |
| 121 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13089535 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12138556 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11553083 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11553083 |
| 125 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11363491 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10535695 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09790031 |
| 128 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08607518 |
| 129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05935249 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05930157 |
| 131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05470906 |
| 132 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05403636 |
| 133 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05120883 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04954809 |
| 135 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04828507 |
| 136 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04546969 |
| 137 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04523451 |
| 138 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04328838 |
| 139 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03933338 |
| 140 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02828772 |
| 141 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00553770 |
| 142 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98755800 |
| 143 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98553242 |
| 144 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98439518 |
| 145 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.97751245 |
| 146 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97459782 |
| 147 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96891217 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96774631 |
| 149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95572293 |
| 150 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95036333 |
| 151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94761277 |
| 152 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94442770 |
| 153 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93776818 |
| 154 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93559732 |
| 155 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93527347 |
| 156 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93521581 |
| 157 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.93127389 |
| 158 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92858966 |
| 159 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92822646 |
| 160 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92004060 |
| 161 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.90724012 |
| 162 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88966495 |
| 163 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88915994 |
| 164 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88874879 |
| 165 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88796134 |
| 166 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.88660586 |
| 167 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88134531 |
| 168 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88070357 |
| 169 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87678171 |
| 170 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87373697 |
| 171 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85516040 |
| 172 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85133953 |
| 173 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84865033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.90999276 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.76152195 |
| 3 | MP0003111_abnormal_nucleus_morphology | 2.88785594 |
| 4 | MP0009840_abnormal_foam_cell | 2.82484406 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.68356294 |
| 6 | MP0003186_abnormal_redox_activity | 2.58686324 |
| 7 | MP0003077_abnormal_cell_cycle | 2.55201564 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.54106478 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.31719461 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.28566139 |
| 11 | MP0005451_abnormal_body_composition | 2.27899120 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.24171729 |
| 13 | MP0006054_spinal_hemorrhage | 2.23438257 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.21105460 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.21105460 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.16623838 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.14564856 |
| 18 | MP0008004_abnormal_stomach_pH | 2.11992120 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.07317510 |
| 20 | MP0004147_increased_porphyrin_level | 2.04384859 |
| 21 | MP0000490_abnormal_crypts_of | 2.02058602 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.94466620 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.92586384 |
| 24 | MP0003724_increased_susceptibility_to | 1.92359162 |
| 25 | MP0003075_altered_response_to | 1.91779282 |
| 26 | MP0008932_abnormal_embryonic_tissue | 1.88894741 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.86432841 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.70862821 |
| 29 | MP0003279_aneurysm | 1.70596694 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.68763233 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.67548854 |
| 32 | MP0005670_abnormal_white_adipose | 1.66148565 |
| 33 | MP0001730_embryonic_growth_arrest | 1.63900941 |
| 34 | MP0000358_abnormal_cell_content/ | 1.59802628 |
| 35 | MP0003786_premature_aging | 1.59520620 |
| 36 | MP0009785_altered_susceptibility_to | 1.59052658 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.56118107 |
| 38 | MP0001958_emphysema | 1.51958362 |
| 39 | MP0003436_decreased_susceptibility_to | 1.51773849 |
| 40 | MP0008260_abnormal_autophagy | 1.47617463 |
| 41 | MP0000343_altered_response_to | 1.45639085 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.43796589 |
| 43 | MP0008058_abnormal_DNA_repair | 1.43491508 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.42102092 |
| 45 | MP0001853_heart_inflammation | 1.40058151 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.40036385 |
| 47 | MP0000858_altered_metastatic_potential | 1.39886097 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.36791594 |
| 49 | MP0003828_pulmonary_edema | 1.35408976 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.35096995 |
| 51 | MP0005166_decreased_susceptibility_to | 1.33782462 |
| 52 | MP0003718_maternal_effect | 1.32966205 |
| 53 | MP0008874_decreased_physiological_sensi | 1.32863463 |
| 54 | MP0000350_abnormal_cell_proliferation | 1.32010799 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.31421429 |
| 56 | MP0001851_eye_inflammation | 1.30767323 |
| 57 | MP0004510_myositis | 1.30344195 |
| 58 | MP0002722_abnormal_immune_system | 1.28976686 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.27355197 |
| 60 | MP0003646_muscle_fatigue | 1.27213269 |
| 61 | MP0001542_abnormal_bone_strength | 1.26824060 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.26248197 |
| 63 | MP0002398_abnormal_bone_marrow | 1.26042441 |
| 64 | MP0009763_increased_sensitivity_to | 1.23902123 |
| 65 | MP0000751_myopathy | 1.23018057 |
| 66 | MP0005025_abnormal_response_to | 1.22374090 |
| 67 | MP0002080_prenatal_lethality | 1.22015210 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.21751249 |
| 69 | MP0000313_abnormal_cell_death | 1.21562226 |
| 70 | MP0004272_abnormal_basement_membrane | 1.20719370 |
| 71 | MP0005671_abnormal_response_to | 1.20427781 |
| 72 | MP0000013_abnormal_adipose_tissue | 1.20407914 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.19604535 |
| 74 | MP0005275_abnormal_skin_tensile | 1.19112698 |
| 75 | MP0004484_altered_response_of | 1.18017578 |
| 76 | MP0002429_abnormal_blood_cell | 1.16419219 |
| 77 | MP0010307_abnormal_tumor_latency | 1.15956404 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.13731454 |
| 79 | MP0000685_abnormal_immune_system | 1.13661221 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 1.13584283 |
| 81 | MP0003123_paternal_imprinting | 1.12757144 |
| 82 | MP0003690_abnormal_glial_cell | 1.12492729 |
| 83 | MP0002419_abnormal_innate_immunity | 1.12409957 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.12246868 |
| 85 | MP0000604_amyloidosis | 1.11127108 |
| 86 | MP0002132_abnormal_respiratory_system | 1.10811787 |
| 87 | MP0002405_respiratory_system_inflammati | 1.10690093 |
| 88 | MP0002972_abnormal_cardiac_muscle | 1.09644799 |
| 89 | MP0002420_abnormal_adaptive_immunity | 1.09557686 |
| 90 | MP0009764_decreased_sensitivity_to | 1.09555194 |
| 91 | MP0001819_abnormal_immune_cell | 1.08973366 |
| 92 | MP0001697_abnormal_embryo_size | 1.08677844 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 1.08282295 |
| 94 | MP0009379_abnormal_foot_pigmentation | 1.08261956 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08015102 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 1.06792091 |
| 97 | MP0002452_abnormal_antigen_presenting | 1.06624167 |
| 98 | MP0003763_abnormal_thymus_physiology | 1.04712865 |
| 99 | MP0001533_abnormal_skeleton_physiology | 1.03623949 |
| 100 | MP0003329_amyloid_beta_deposits | 1.03510968 |
| 101 | MP0000249_abnormal_blood_vessel | 1.02378801 |
| 102 | MP0000716_abnormal_immune_system | 1.02313055 |
| 103 | MP0000747_muscle_weakness | 1.00307999 |
| 104 | MP0002723_abnormal_immune_serum | 0.99396868 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99331656 |
| 106 | MP0002971_abnormal_brown_adipose | 0.97854405 |
| 107 | MP0008057_abnormal_DNA_replication | 0.97748096 |
| 108 | MP0005084_abnormal_gallbladder_morpholo | 0.96097094 |
| 109 | MP0003303_peritoneal_inflammation | 0.96016699 |
| 110 | MP0000920_abnormal_myelination | 0.94155825 |
| 111 | MP0005164_abnormal_response_to | 0.93720100 |
| 112 | MP0008469_abnormal_protein_level | 0.92862815 |
| 113 | MP0006138_congestive_heart_failure | 0.92507310 |
| 114 | MP0005330_cardiomyopathy | 0.92088507 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.91286094 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.90991861 |
| 117 | MP0005535_abnormal_body_temperature | 0.90969957 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.90958394 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.89581597 |
| 120 | MP0003984_embryonic_growth_retardation | 0.88301648 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.87742463 |
| 122 | MP0005385_cardiovascular_system_phenoty | 0.87742463 |
| 123 | MP0000681_abnormal_thyroid_gland | 0.87444800 |
| 124 | MP0005023_abnormal_wound_healing | 0.86923102 |
| 125 | MP0000749_muscle_degeneration | 0.86361978 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.86019636 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.85970946 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.85709830 |
| 129 | MP0002088_abnormal_embryonic_growth/wei | 0.85614776 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.84875553 |
| 131 | MP0005380_embryogenesis_phenotype | 0.84826688 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.84826688 |
| 133 | MP0005165_increased_susceptibility_to | 0.84750333 |
| 134 | MP0004859_abnormal_synaptic_plasticity | 0.84395352 |
| 135 | MP0005636_abnormal_mineral_homeostasis | 0.84166725 |
| 136 | MP0003091_abnormal_cell_migration | 0.84028293 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.81655801 |
| 138 | MP0003448_altered_tumor_morphology | 0.81646292 |
| 139 | MP0001756_abnormal_urination | 0.81638803 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.81314213 |
| 141 | MP0005623_abnormal_meninges_morphology | 0.81161438 |
| 142 | MP0002086_abnormal_extraembryonic_tissu | 0.81151101 |
| 143 | MP0004130_abnormal_muscle_cell | 0.79547907 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.78848755 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.78720186 |
| 146 | MP0001800_abnormal_humoral_immune | 0.77655449 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.77517875 |
| 148 | MP0009278_abnormal_bone_marrow | 0.77352745 |
| 149 | MP0005384_cellular_phenotype | 0.76709447 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.75367808 |
| 151 | MP0005319_abnormal_enzyme/_coenzyme | 0.73143876 |
| 152 | MP0004947_skin_inflammation | 0.72954080 |
| 153 | MP0005075_abnormal_melanosome_morpholog | 0.72832359 |
| 154 | MP0006082_CNS_inflammation | 0.72330668 |
| 155 | MP0004145_abnormal_muscle_electrophysio | 0.71416003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.88959561 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.79644753 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.54720545 |
| 4 | Purpura (HP:0000979) | 4.46146933 |
| 5 | Increased mean platelet volume (HP:0011877) | 4.14791370 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.08979470 |
| 7 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.08979470 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.98565475 |
| 9 | Epistaxis (HP:0000421) | 3.69351730 |
| 10 | Poor head control (HP:0002421) | 3.47463193 |
| 11 | Menorrhagia (HP:0000132) | 3.44598852 |
| 12 | Gingival bleeding (HP:0000225) | 3.43495662 |
| 13 | Reticulocytopenia (HP:0001896) | 3.40531020 |
| 14 | Breast hypoplasia (HP:0003187) | 3.38159639 |
| 15 | Progressive muscle weakness (HP:0003323) | 3.37654893 |
| 16 | Birth length less than 3rd percentile (HP:0003561) | 3.36967109 |
| 17 | Abnormality of alanine metabolism (HP:0010916) | 3.30675033 |
| 18 | Hyperalaninemia (HP:0003348) | 3.30675033 |
| 19 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.30675033 |
| 20 | Multiple enchondromatosis (HP:0005701) | 3.17692616 |
| 21 | Carpal bone hypoplasia (HP:0001498) | 3.15099690 |
| 22 | Hepatosplenomegaly (HP:0001433) | 3.07678148 |
| 23 | Cerebral hypomyelination (HP:0006808) | 3.03814511 |
| 24 | Hepatic necrosis (HP:0002605) | 3.01064875 |
| 25 | Hepatocellular necrosis (HP:0001404) | 2.96293651 |
| 26 | Rough bone trabeculation (HP:0100670) | 2.93170374 |
| 27 | Macrocytic anemia (HP:0001972) | 2.91507064 |
| 28 | Microretrognathia (HP:0000308) | 2.90848899 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.85123263 |
| 30 | Trismus (HP:0000211) | 2.83733987 |
| 31 | Petechiae (HP:0000967) | 2.83652896 |
| 32 | Increased serum lactate (HP:0002151) | 2.83242645 |
| 33 | Obstructive lung disease (HP:0006536) | 2.83053262 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83053262 |
| 35 | Degeneration of anterior horn cells (HP:0002398) | 2.79584163 |
| 36 | Abnormality of the anterior horn cell (HP:0006802) | 2.79584163 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.71155066 |
| 38 | Axonal loss (HP:0003447) | 2.70973985 |
| 39 | Aplastic anemia (HP:0001915) | 2.69643628 |
| 40 | Abnormal platelet function (HP:0011869) | 2.67486217 |
| 41 | Impaired platelet aggregation (HP:0003540) | 2.67486217 |
| 42 | Oral leukoplakia (HP:0002745) | 2.66576014 |
| 43 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.65853968 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.65008519 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.64309406 |
| 46 | Increased CSF lactate (HP:0002490) | 2.61971323 |
| 47 | Mitochondrial inheritance (HP:0001427) | 2.61422672 |
| 48 | Nausea (HP:0002018) | 2.61111937 |
| 49 | Pallor (HP:0000980) | 2.60196780 |
| 50 | Nemaline bodies (HP:0003798) | 2.59991493 |
| 51 | Muscle fiber splitting (HP:0003555) | 2.57226965 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.55614631 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.51817916 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.51741667 |
| 55 | Conjunctival telangiectasia (HP:0000524) | 2.51015132 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.50931235 |
| 57 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.48877258 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46721081 |
| 59 | Personality changes (HP:0000751) | 2.44296805 |
| 60 | Exertional dyspnea (HP:0002875) | 2.43886564 |
| 61 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41927710 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.39805875 |
| 63 | Amyloidosis (HP:0011034) | 2.38849439 |
| 64 | Muscle fiber inclusion bodies (HP:0100299) | 2.38827174 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38701507 |
| 66 | Lactic acidosis (HP:0003128) | 2.38007039 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.37085321 |
| 68 | Sparse eyelashes (HP:0000653) | 2.35980463 |
| 69 | Polycythemia (HP:0001901) | 2.35027913 |
| 70 | Abnormality of the umbilical cord (HP:0010881) | 2.34444744 |
| 71 | Death in infancy (HP:0001522) | 2.30584671 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.29783211 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29703852 |
| 74 | Abnormal hemoglobin (HP:0011902) | 2.28732033 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.28507676 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.28494235 |
| 77 | Type 1 muscle fiber predominance (HP:0003803) | 2.26646101 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.24542927 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.24385332 |
| 80 | Patent foramen ovale (HP:0001655) | 2.24109919 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22526842 |
| 82 | CNS demyelination (HP:0007305) | 2.22344205 |
| 83 | Abnormal protein glycosylation (HP:0012346) | 2.20405330 |
| 84 | Abnormal glycosylation (HP:0012345) | 2.20405330 |
| 85 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20405330 |
| 86 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20405330 |
| 87 | Increased serum ferritin (HP:0003281) | 2.19767896 |
| 88 | Exercise-induced myalgia (HP:0003738) | 2.19059340 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18960669 |
| 90 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18586581 |
| 91 | Myocardial infarction (HP:0001658) | 2.17065814 |
| 92 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16878626 |
| 93 | Recurrent abscess formation (HP:0002722) | 2.16738207 |
| 94 | Myoglobinuria (HP:0002913) | 2.15257733 |
| 95 | Paralysis (HP:0003470) | 2.13295847 |
| 96 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.11698350 |
| 97 | Nonimmune hydrops fetalis (HP:0001790) | 2.11472131 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.11270754 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09851225 |
| 100 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09851225 |
| 101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09851225 |
| 102 | Respiratory difficulties (HP:0002880) | 2.09832891 |
| 103 | IgM deficiency (HP:0002850) | 2.09369456 |
| 104 | Respiratory failure (HP:0002878) | 2.08572106 |
| 105 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08328331 |
| 106 | Poikilocytosis (HP:0004447) | 2.08285937 |
| 107 | Exercise intolerance (HP:0003546) | 2.08039747 |
| 108 | Protrusio acetabuli (HP:0003179) | 2.07296434 |
| 109 | Postnatal microcephaly (HP:0005484) | 2.07039742 |
| 110 | Cerebral hemorrhage (HP:0001342) | 2.07000849 |
| 111 | Premature rupture of membranes (HP:0001788) | 2.06341576 |
| 112 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.06153457 |
| 113 | Eczematoid dermatitis (HP:0000976) | 2.06096768 |
| 114 | Slender long bone (HP:0003100) | 2.05649356 |
| 115 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.05486830 |
| 116 | Hyperlipoproteinemia (HP:0010980) | 2.05110910 |
| 117 | Premature ovarian failure (HP:0008209) | 2.02689612 |
| 118 | Scanning speech (HP:0002168) | 2.01740122 |
| 119 | Hyporeflexia of lower limbs (HP:0002600) | 1.99887458 |
| 120 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.99509069 |
| 121 | Recurrent bacterial skin infections (HP:0005406) | 1.99271307 |
| 122 | Abnormal trabecular bone morphology (HP:0100671) | 1.95794944 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 1.95061285 |
| 124 | Emotional lability (HP:0000712) | 1.93041293 |
| 125 | Acute encephalopathy (HP:0006846) | 1.92111107 |
| 126 | Reticulocytosis (HP:0001923) | 1.92041958 |
| 127 | Thrombocytosis (HP:0001894) | 1.91916367 |
| 128 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91655204 |
| 129 | Ragged-red muscle fibers (HP:0003200) | 1.91621942 |
| 130 | Cholecystitis (HP:0001082) | 1.90450801 |
| 131 | Abnormal gallbladder physiology (HP:0012438) | 1.90450801 |
| 132 | Loss of speech (HP:0002371) | 1.89810907 |
| 133 | Muscle stiffness (HP:0003552) | 1.89505889 |
| 134 | Esophageal neoplasm (HP:0100751) | 1.89112837 |
| 135 | Neoplasm of head and neck (HP:0012288) | 1.89112837 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.88738125 |
| 137 | Megaloblastic anemia (HP:0001889) | 1.87456857 |
| 138 | Cellulitis (HP:0100658) | 1.87215807 |
| 139 | Fatigue (HP:0012378) | 1.86338932 |
| 140 | Abnormality of glycolysis (HP:0004366) | 1.86003697 |
| 141 | Increased serum pyruvate (HP:0003542) | 1.86003697 |
| 142 | Abnormality of reticulocytes (HP:0004312) | 1.85069066 |
| 143 | Secondary amenorrhea (HP:0000869) | 1.84715337 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.84646798 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.83958060 |
| 146 | Mutism (HP:0002300) | 1.83520017 |
| 147 | Progressive neurologic deterioration (HP:0002344) | 1.83429965 |
| 148 | Cholelithiasis (HP:0001081) | 1.83234383 |
| 149 | Pustule (HP:0200039) | 1.82139794 |
| 150 | Delusions (HP:0000746) | 1.81460862 |
| 151 | Unsteady gait (HP:0002317) | 1.80727137 |
| 152 | CNS hypomyelination (HP:0003429) | 1.80423139 |
| 153 | Pancytopenia (HP:0001876) | 1.80250636 |
| 154 | Abnormality of the tricuspid valve (HP:0001702) | 1.79386771 |
| 155 | Diplopia (HP:0000651) | 1.79380207 |
| 156 | Abnormality of binocular vision (HP:0011514) | 1.79380207 |
| 157 | Muscle fiber atrophy (HP:0100295) | 1.79038740 |
| 158 | Tetraparesis (HP:0002273) | 1.78469933 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.77697710 |
| 160 | Episodic fever (HP:0001954) | 1.76523134 |
| 161 | Bruising susceptibility (HP:0000978) | 1.76128603 |
| 162 | Foot dorsiflexor weakness (HP:0009027) | 1.75927458 |
| 163 | Abnormality of complement system (HP:0005339) | 1.75194325 |
| 164 | Abnormality of the foot musculature (HP:0001436) | 1.74861819 |
| 165 | Hypertensive crisis (HP:0100735) | 1.74805993 |
| 166 | Mucosal telangiectasiae (HP:0100579) | 1.71916468 |
| 167 | Hemorrhage of the eye (HP:0011885) | 1.71688260 |
| 168 | Neurofibrillary tangles (HP:0002185) | 1.69928734 |
| 169 | Spinal rigidity (HP:0003306) | 1.69773062 |
| 170 | Increased connective tissue (HP:0009025) | 1.67197770 |
| 171 | Distal lower limb amyotrophy (HP:0008944) | 1.66167787 |
| 172 | Acanthocytosis (HP:0001927) | 1.65695285 |
| 173 | Neck muscle weakness (HP:0000467) | 1.64955810 |
| 174 | Abnormal gallbladder morphology (HP:0012437) | 1.62953372 |
| 175 | Chest pain (HP:0100749) | 1.62826376 |
| 176 | Peritonitis (HP:0002586) | 1.61856629 |
| 177 | Abnormality of lateral ventricle (HP:0030047) | 1.61406536 |
| 178 | Diminished motivation (HP:0000745) | 1.60104386 |
| 179 | Thrombophlebitis (HP:0004418) | 1.59962659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.68796574 |
| 2 | NME2 | 4.27225722 |
| 3 | WEE1 | 3.82612854 |
| 4 | STK16 | 3.33287872 |
| 5 | RIPK4 | 3.18244084 |
| 6 | TESK2 | 3.08281674 |
| 7 | EIF2AK1 | 3.06436656 |
| 8 | KDR | 2.90486179 |
| 9 | PIM2 | 2.71544049 |
| 10 | BMPR2 | 2.45356121 |
| 11 | ACVR1B | 2.37679989 |
| 12 | TESK1 | 2.34907038 |
| 13 | NEK1 | 2.23940549 |
| 14 | MAP3K11 | 2.06986891 |
| 15 | SCYL2 | 1.98063828 |
| 16 | PIK3CG | 1.96701446 |
| 17 | EPHA2 | 1.94287112 |
| 18 | MAP3K13 | 1.80379960 |
| 19 | BRSK2 | 1.78762599 |
| 20 | TRIB3 | 1.75984375 |
| 21 | EIF2AK3 | 1.65644437 |
| 22 | PLK4 | 1.60226438 |
| 23 | RPS6KA4 | 1.59616398 |
| 24 | NEK2 | 1.59137859 |
| 25 | BCKDK | 1.58140017 |
| 26 | FES | 1.55963427 |
| 27 | MST4 | 1.55124851 |
| 28 | DYRK3 | 1.48081635 |
| 29 | ARAF | 1.47627082 |
| 30 | PRPF4B | 1.46832193 |
| 31 | TSSK6 | 1.42477062 |
| 32 | MAP3K6 | 1.38261373 |
| 33 | TTN | 1.37384751 |
| 34 | BLK | 1.34989854 |
| 35 | LIMK1 | 1.33800308 |
| 36 | LRRK2 | 1.31063319 |
| 37 | MAP3K12 | 1.29931580 |
| 38 | PAK4 | 1.28070601 |
| 39 | MAPKAPK3 | 1.24157596 |
| 40 | ERN1 | 1.24057897 |
| 41 | MAPK12 | 1.20161234 |
| 42 | KSR2 | 1.19704227 |
| 43 | MAP3K1 | 1.18605924 |
| 44 | BRSK1 | 1.17007348 |
| 45 | MAP4K1 | 1.15408257 |
| 46 | ZAP70 | 1.14936954 |
| 47 | NTRK1 | 1.14433815 |
| 48 | TBK1 | 1.11258959 |
| 49 | ILK | 1.08798200 |
| 50 | SYK | 1.04584575 |
| 51 | NME1 | 1.01801870 |
| 52 | CSF1R | 1.01732761 |
| 53 | VRK1 | 1.01701440 |
| 54 | PLK1 | 1.01530291 |
| 55 | MAP3K8 | 1.01190795 |
| 56 | AURKA | 1.00155991 |
| 57 | IRAK3 | 1.00055589 |
| 58 | PKN2 | 0.99257384 |
| 59 | BRAF | 0.97874943 |
| 60 | ABL2 | 0.95265086 |
| 61 | TAOK3 | 0.95165908 |
| 62 | MAP3K14 | 0.94949966 |
| 63 | BMX | 0.94269696 |
| 64 | GRK5 | 0.92879063 |
| 65 | FLT3 | 0.92475874 |
| 66 | OBSCN | 0.92462082 |
| 67 | CAMKK2 | 0.92185245 |
| 68 | PAK6 | 0.91924682 |
| 69 | MATK | 0.91665199 |
| 70 | PDK3 | 0.90772017 |
| 71 | PDK4 | 0.90772017 |
| 72 | MAP2K3 | 0.90324868 |
| 73 | NEK9 | 0.89403730 |
| 74 | CCNB1 | 0.88748410 |
| 75 | PDK2 | 0.87570634 |
| 76 | RPS6KB2 | 0.85673057 |
| 77 | TTK | 0.83711616 |
| 78 | CDK7 | 0.83217200 |
| 79 | TAOK2 | 0.82563966 |
| 80 | PAK1 | 0.81999099 |
| 81 | SRPK1 | 0.80383921 |
| 82 | CDC7 | 0.79543318 |
| 83 | ROCK2 | 0.78508316 |
| 84 | AURKB | 0.78331116 |
| 85 | TLK1 | 0.78217854 |
| 86 | PTK2B | 0.77920870 |
| 87 | CSK | 0.76485021 |
| 88 | CAMK2G | 0.76168358 |
| 89 | MAP3K3 | 0.75935439 |
| 90 | DMPK | 0.74872643 |
| 91 | TGFBR1 | 0.74515095 |
| 92 | LATS2 | 0.73917960 |
| 93 | TAOK1 | 0.73140769 |
| 94 | TRPM7 | 0.72587769 |
| 95 | MAP2K4 | 0.72543959 |
| 96 | STK10 | 0.71470774 |
| 97 | FGR | 0.69878111 |
| 98 | CDK19 | 0.69772263 |
| 99 | PDPK1 | 0.67924570 |
| 100 | LYN | 0.64685971 |
| 101 | PINK1 | 0.63574805 |
| 102 | MYLK | 0.63462127 |
| 103 | JAK2 | 0.62485468 |
| 104 | MAP3K5 | 0.62474242 |
| 105 | PLK2 | 0.62006627 |
| 106 | TIE1 | 0.61088941 |
| 107 | CDK6 | 0.59617687 |
| 108 | HCK | 0.59174649 |
| 109 | DAPK3 | 0.57305507 |
| 110 | DDR2 | 0.56853461 |
| 111 | RIPK1 | 0.56789624 |
| 112 | TYK2 | 0.56615221 |
| 113 | RAF1 | 0.56149893 |
| 114 | PRKD1 | 0.55866495 |
| 115 | JAK1 | 0.55522025 |
| 116 | PRKG2 | 0.55116922 |
| 117 | PIM1 | 0.54993207 |
| 118 | KIT | 0.54722200 |
| 119 | PAK2 | 0.54502770 |
| 120 | ERBB3 | 0.53543464 |
| 121 | DAPK1 | 0.53281102 |
| 122 | MAP2K2 | 0.52973484 |
| 123 | JAK3 | 0.52600689 |
| 124 | STK4 | 0.52501035 |
| 125 | CAMK2B | 0.50553211 |
| 126 | EPHA3 | 0.49561520 |
| 127 | DAPK2 | 0.49045758 |
| 128 | CDK4 | 0.47859709 |
| 129 | CAMK2D | 0.46397235 |
| 130 | CSNK2A1 | 0.45717391 |
| 131 | PDK1 | 0.44748317 |
| 132 | MAPK4 | 0.44133831 |
| 133 | STK24 | 0.43835696 |
| 134 | ROCK1 | 0.42528852 |
| 135 | PRKCI | 0.41987049 |
| 136 | CDK11A | 0.41731029 |
| 137 | MARK3 | 0.40186179 |
| 138 | BTK | 0.37773111 |
| 139 | CHEK2 | 0.36030450 |
| 140 | PLK3 | 0.33549439 |
| 141 | PBK | 0.32380169 |
| 142 | TEC | 0.31223295 |
| 143 | CDK14 | 0.31222885 |
| 144 | ZAK | 0.29359236 |
| 145 | CDK8 | 0.29351564 |
| 146 | GRK6 | 0.29275946 |
| 147 | CSNK2A2 | 0.28535726 |
| 148 | MAPKAPK2 | 0.28041830 |
| 149 | IKBKB | 0.26079201 |
| 150 | MOS | 0.24652849 |
| 151 | DYRK2 | 0.24594715 |
| 152 | MAP2K6 | 0.24506077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.04466474 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.25193128 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.11004820 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.34253819 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.83960727 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.80123155 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.55616455 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.52499054 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.34151450 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21378344 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.20303925 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.19765424 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.17017485 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 2.07571628 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.07509919 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.96501046 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96007446 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.94347908 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93486754 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91801900 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88284243 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.87864223 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.86181973 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.85758957 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74637548 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74421446 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.73311957 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73214376 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72487990 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.69862111 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.62294394 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.57128047 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55421063 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45036577 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44792308 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41996694 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.34817752 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.33500808 |
| 39 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27675331 |
| 40 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24559987 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.24211277 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23122957 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22401777 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21101738 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.21036576 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20398492 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17727741 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17250643 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16584715 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16540122 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.14656437 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13447716 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12813460 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12239326 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11792868 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11529666 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10346422 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01764895 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01218825 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98458038 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.94956329 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94771813 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94130715 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 0.94037168 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91931535 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90839550 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90221628 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89090248 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88481485 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88387700 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87494726 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82021212 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80658158 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78872020 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77774573 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76480177 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76331634 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76068892 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75606948 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70940452 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70890830 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.67158485 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66703507 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66552320 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66407081 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64793658 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64642377 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64286226 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63161751 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61841862 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60947165 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58486926 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58265430 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56889919 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55464130 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55422709 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55385802 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54396255 |
| 99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53692707 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52492504 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.50123804 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50114750 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49634938 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49510117 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49445098 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49188952 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.49043755 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47025159 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46613935 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46552223 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46487802 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46383004 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44780049 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44697266 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43333739 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43315386 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.43217163 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.42298895 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.41917711 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40880671 |
| 121 | Measles_Homo sapiens_hsa05162 | 0.40104738 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39843613 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.39714808 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39511746 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.38270389 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37467361 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36406397 |
| 128 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36386381 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34730399 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34027483 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33957680 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33201654 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33037810 |
| 134 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32186952 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32055914 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31226962 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30261093 |
| 138 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29820302 |
| 139 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29743930 |
| 140 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28559827 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.28239328 |
| 142 | Malaria_Homo sapiens_hsa05144 | 0.27594953 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27393163 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26727864 |
| 145 | * Endocytosis_Homo sapiens_hsa04144 | 0.26062314 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24962886 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23820749 |
| 148 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23741098 |
| 149 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23594041 |
| 150 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.22624489 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.22093215 |
| 152 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.21681415 |
| 153 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18240634 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.17969065 |

